SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

TheraKine to Present at Biotech Showcase in San Francisco

LOS ANGELES, CA -- (Marketwired) -- 01/10/14 -- TheraKine Limited ( has been selected to present at the 2014 Biotech Showcase™ in San Francisco. Stan Yakatan, CEO of TheraKine, will provide information on the company's novel sustained-release delivery platform for the local delivery of biologics and small molecules.

TheraKine's tunable, sustained-release technology enables linear release of drug products with durations from weeks to months, resolving numerous delivery challenges. The technology is applicable in many disease therapies, addressing the $60 billion global market for biologic drugs.

Mr. Yakatan will be presenting on Monday, January 13, 2014, at 9:30 AM in the Hearst Room of the Parc 55 Wyndham San Francisco - Union Square. The conference will take place Monday, January 13, through Wednesday, January 15, 2014.

Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Now in its sixth year, Biotech Showcase is expected to attract upwards of 1,700 attendees.

About TheraKine
TheraKine Limited is a privately held drug delivery company. Founded in 2007, the company has developed novel drug delivery technology for biologics and small molecules that address drug delivery challenges in multiple therapeutic areas. The Company has multiple patents approved, pending, and in preparation.

Company contact:
Stan Yakatan
Email Contact

Media contact:
Lynn Hood
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.